(Rac)-Managlinat dialanetil
(Rac)-Managlinat dialanetil Rac)-MB06322) is a compound for the inhibition of type 2 diabetes that is in Phase II clinical trials and works by inhibiting gluconeogenesis.
Interne Referenz:
cell25sk21015